Archives for February 2010

Study Shows Twice Weekly Etanercept (Enbrel) Clears Psoriasis Lesions More Quickly Than Once Weekly Treatment

Initial treatment with twice weekly etanercept (Enbrel), a tumour necrosis factor antagonist, achieves more rapid clearance of skin lesions than once weekly treatment in patients with active psoriasis and psoriatic arthritis, according to results from the PRESTA study reported recently in the British Medical Journal…

26 February 2010 | 961607 | No Comments

New Study Finds Similar Advertising Strategies Used By Indoor Tanning And Tobacco Industries

While the proven negative health consequences of smoking and tanning are undeniable, tobacco and indoor tanning advertisers would like consumers to think otherwise. In fact, a new study comparing the tactics used in advertising tobacco and indoor tanning products found several similarities in how these two industries market unhealthy products…

26 February 2010 | 961611 | No Comments

Dermatology Study Identifies Genetic Key In Treatment Of Female Hair Loss

Molecular dermatology research and development innovator HairDX announced the results of a six month pilot study that presents, for the first time, evidence that genetic mechanisms may predict treatment response to Finasteride for postmenopausal female Androgenetic Alopecia (female hair loss)…

25 February 2010 | 961615 | No Comments

What Is Liposuction? What Are The Risks And Benefits Of Liposuction?

Liposuction, also called lipoplasty, liposculpture suction lipectomy, or lipo is a type of cosmetic surgery which breaks up and “sucks” fat from various possible parts of the body, most commonly the abdomen, thighs, buttocks, neck, chin, upper and backs of the arms, calves, and back. The fat is removed through a hollow instrument - a [...]

25 February 2010 | Uncategorized | No Comments

New FDA Approved Treatment For Head Lice Is Safe And Effective In Children As Young As 6 Months Old

A new non-neurotoxic treatment for head lice has been found to have an average of 91.2% treatment success rate after one week, and to be safe in humans from six months of age and up. This is the finding of a study published in Pediatric Dermatology…

25 February 2010 | 961619 | No Comments

Study Showed Sculptra(R) Aesthetic Effectively Corrects Nasolabial Folds And Other Facial Wrinkles

Results published in today’s online issue of the Journal of American Academy of Dermatology showed that treatment with Sculptra®Aesthetic (injectable poly-L-lactic acid) was significantly more effective than a human-derived collagen treatment CosmoPlast® in correcting shallow to deep nasolabial fold (NLF) wrinkles (smile lines)…

24 February 2010 | 961971 | No Comments

News From The Journal Of Clinical Investigation: Feb. 22, 2010

VIROLOGY: Successfully modeling hepatitis B and C virus infection Hepatitis B virus (HBV) and hepatitis C virus (HCV) infect liver cells, and persistent infection can lead to cirrhosis of the liver and/or a form of liver cancer known as hepatocellular carcinoma…

23 February 2010 | 961975 | No Comments

Mayo Clinic Health Letter: Highlights From The February Issue

Here are highlights from the February issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit http://www.HealthLetter.MayoClinic.com…

22 February 2010 | 961983 | No Comments

Regulatory Science Update: FDA And International Serious Adverse Events Consortium Complete Third Data Release

The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) announced the third release of data on the genetic basis of drug-induced liver injury (DILI) and serious skin reactions (SSRs). The data focus on the genetics associated with DILI and SSR and may help researchers to better predict an individual’s [...]

22 February 2010 | 961979 | No Comments

TEI Biosciences’ PriMatrix(TM) Awarded Seal Of Approval By American Podiatric Medical Association

TEI Biosciences Inc. announced that its PriMatrix™ Dermal Repair Scaffold has been awarded the coveted American Podiatric Medical Association’s (APMA) Seal of Approval. PriMatrix is a bioactive collagen matrix used in the management of diabetic and venous ulcers, second-degree burns, and surgical and trauma wounds…

20 February 2010 | 961987 | No Comments

Navigation

News Archives

Sponsors